Catalyst Pharmaceuticals, Inc. - Common Stock — Bilan trimestriel (NASDAQ:CPRX) | MetaTrader

Afficher le graphique complet Full chart

Nouvelles

Why Catalyst Pharmaceutical (CPRX) is a Top Momentum Stock for the Long-Term

Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term

CPRX or UTHR: Which Is the Better Value Stock Right Now?

Catalyst Pharmaceuticals Q1 Earnings Beat, Firdapse Revenues Rise Y/Y

Le BPA de Catalyst Pharmaceuticals a dépassé les attentes de 0,06$, le CA a surpassé les prévisions

Catalyst (CPRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Catalyst Pharmaceutical (CPRX) Surpasses Q1 Earnings and Revenue Estimates

Perrigo Q1 Earnings Surpass Estimates, Sales Miss, Both Fall Y/Y

UTHR Q1 Earnings Miss Estimates, Shares Jump on Strong Outlook

La société familiale Angelini Pharma rachète Catalyst Pharmaceuticals pour plus de 4 milliards | Benzinga France

ACAD Q1 Earnings & Revenues Miss Estimates Despite Y/Y Sales Growth

Madrigal Q1 Earnings Beat, MASH Drug Sales Drive Top Line, Stock Up